$Xilio Therapeutics (XLO.US)$ Xilio Therapeutics Q1 2024 GAA...
$Xilio Therapeutics(XLO.US$ Xilio Therapeutics Q1 2024 GAAP EPS $(0.62) Compared To $(0.83) A Year Ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Trytosaveabit OP : Xilio Therapeutics' Q1 Cash And Cash Equivalents Of $34M, $30M Upfront Payment Received In April 2024 Under Gilead Agreement And Approximately $14.6M In Gross Proceeds From Private Placement In April 2024 Are Expected To Provide Cash Runway Into Q2 2025
Jaguar8 Trytosaveabit OP : This i like!
Trytosaveabit OP Jaguar8 : As do I!